{"data":{"type":"company_profile_ai","id":75254,"entity_id":"wefunder:company:75254","attributes":{"canonical_url":"https://wefunder.com/biosmart.research.inc","retrieval_urls":{"canonical":"https://wefunder.com/biosmart.research.inc","json":"https://wefunder.com/biosmart.research.inc.json","markdown":"https://wefunder.com/biosmart.research.inc.md","ai_json":"https://wefunder.com/biosmart.research.inc.ai.json","ai_text":"https://wefunder.com/biosmart.research.inc.ai.txt","changelog_json":"https://wefunder.com/biosmart.research.inc.changelog.json","schema":"https://wefunder.com/.well-known/ai-profile-schema.json"},"updated_at":"2026-06-22T05:03:15Z","generated_at":"2026-06-23T02:24:45Z","profile_visibility":{"owner_published":true,"public_search_results":true,"site_search_listed":true,"privacy_mode":"promote","invite_only":false},"company":{"id":75254,"entity_id":"wefunder:company:75254","slug":"biosmart.research.inc","name":"BioSmart Research, Inc.","tagline":"BioSmart Research: Invest in the future of cannabinoid therapy.","elevator_pitch":"BioSmart Research produces CBD isolate formulas for topical and internal use","location":"Yelm, WA","website":"https://biosmartresearchcbd.com","total_amount_raised":53200,"total_investors":21,"is_funded":true,"is_active":true},"key_claims":[{"claim_id":"claim-total-raised","text":"Total raised on Wefunder: 53200","citation":"https://wefunder.com/biosmart.research.inc#claim-total-raised","provenance":{"source":"FrontCompanySummary#amount_raised","last_verified_at":"2026-06-22T05:03:15Z","as_of":"2026-06-23T02:24:45Z","confidence":"high"},"observed_at":"2026-06-22T05:03:15Z","expires_at":"2026-06-23T05:03:15Z"},{"claim_id":"claim-total-investors","text":"Total investors: 21","citation":"https://wefunder.com/biosmart.research.inc#claim-total-investors","provenance":{"source":"FrontCompanySummary#number_of_investors","last_verified_at":"2026-06-22T05:03:15Z","as_of":"2026-06-23T02:24:45Z","confidence":"high"},"observed_at":"2026-06-22T05:03:15Z","expires_at":"2026-06-23T05:03:15Z"}],"verified_facts":[{"claim_id":"claim-total-raised","text":"Total raised on Wefunder: 53200","citation":"https://wefunder.com/biosmart.research.inc#claim-total-raised","provenance":{"source":"FrontCompanySummary#amount_raised","last_verified_at":"2026-06-22T05:03:15Z","as_of":"2026-06-23T02:24:45Z","confidence":"high"},"observed_at":"2026-06-22T05:03:15Z","expires_at":"2026-06-23T05:03:15Z"},{"claim_id":"claim-total-investors","text":"Total investors: 21","citation":"https://wefunder.com/biosmart.research.inc#claim-total-investors","provenance":{"source":"FrontCompanySummary#number_of_investors","last_verified_at":"2026-06-22T05:03:15Z","as_of":"2026-06-23T02:24:45Z","confidence":"high"},"observed_at":"2026-06-22T05:03:15Z","expires_at":"2026-06-23T05:03:15Z"}],"company_claims":{"tagline":"BioSmart Research: Invest in the future of cannabinoid therapy.","elevator_pitch":"BioSmart Research produces CBD isolate formulas for topical and internal use","story":"Disclaimer: These projections cannot be guaranteedDisclaimer: These projections cannot be guaranteed","quick_facts":["Launch in 2019 produced $1.7M in sales","Biosmart produces pain management and anti-anxiety formulas for clinical and retail distribution","BioSmart has a 3-year technology lead using high-pressure liquid chromatography for isolate extraction","BioSmart markets through it's own retail dispensaries, healthcare providers, pharmacies, affiliates, and internet sales","U.S. Market for non-steroidal OTC pain relievers is $21.9 B/yr. US CBD market is $4.7 B/yr.","Clinical dosing levels with CBD isolates produce similar results to OTC pain relievers without the side effects.","BioSmart collaborates with university and clinical researchers and is a member of Choose Wisely, a patient forum","BioSmart Research represents a responsible approach to improving quality of life and advancing cannabinoid research"]},"computed_metrics":{"total_amount_raised":53200,"total_investors":21,"team_size":1,"featured_investor_count":1,"faq_count":2,"recent_post_count":0},"quick_facts":[{"claim_id":"claim-fact-1","value":"Launch in 2019 produced $1.7M in sales","citation":"https://wefunder.com/biosmart.research.inc#claim-fact-1","observed_at":"2026-06-22T05:03:15Z","expires_at":"2026-06-29T05:03:15Z"},{"claim_id":"claim-fact-2","value":"Biosmart produces pain management and anti-anxiety formulas for clinical and retail distribution","citation":"https://wefunder.com/biosmart.research.inc#claim-fact-2","observed_at":"2026-06-22T05:03:15Z","expires_at":"2026-06-29T05:03:15Z"},{"claim_id":"claim-fact-3","value":"BioSmart has a 3-year technology lead using high-pressure liquid chromatography for isolate extraction","citation":"https://wefunder.com/biosmart.research.inc#claim-fact-3","observed_at":"2026-06-22T05:03:15Z","expires_at":"2026-06-29T05:03:15Z"},{"claim_id":"claim-fact-4","value":"BioSmart markets through it's own retail dispensaries, healthcare providers, pharmacies, affiliates, and internet sales","citation":"https://wefunder.com/biosmart.research.inc#claim-fact-4","observed_at":"2026-06-22T05:03:15Z","expires_at":"2026-06-29T05:03:15Z"},{"claim_id":"claim-fact-5","value":"U.S. Market for non-steroidal OTC pain relievers is $21.9 B/yr. US CBD market is $4.7 B/yr.","citation":"https://wefunder.com/biosmart.research.inc#claim-fact-5","observed_at":"2026-06-22T05:03:15Z","expires_at":"2026-06-29T05:03:15Z"},{"claim_id":"claim-fact-6","value":"Clinical dosing levels with CBD isolates produce similar results to OTC pain relievers without the side effects.","citation":"https://wefunder.com/biosmart.research.inc#claim-fact-6","observed_at":"2026-06-22T05:03:15Z","expires_at":"2026-06-29T05:03:15Z"},{"claim_id":"claim-fact-7","value":"BioSmart collaborates with university and clinical researchers and is a member of Choose Wisely, a patient forum","citation":"https://wefunder.com/biosmart.research.inc#claim-fact-7","observed_at":"2026-06-22T05:03:15Z","expires_at":"2026-06-29T05:03:15Z"},{"claim_id":"claim-fact-8","value":"BioSmart Research represents a responsible approach to improving quality of life and advancing cannabinoid research","citation":"https://wefunder.com/biosmart.research.inc#claim-fact-8","observed_at":"2026-06-22T05:03:15Z","expires_at":"2026-06-29T05:03:15Z"}],"latest_fundraise":{"id":41077,"entity_id":"wefunder:fundraise:41077","state":"successful","offering_type":"506(b)","structure":"ttw","testing_the_waters":true,"can_invest_now":false,"funding_started_at":null,"funding_closed_at":null},"investor_memos":[],"team":[{"id":1331835,"entity_id":"wefunder:company_role:1331835","name":"B Renee Searle","title":"CEO","role":"founder","profile_url":"https://wefunder.com/b.renee.searle.2"}],"featured_investors":[{"id":5443,"entity_id":"wefunder:company_investor_profile:5443","name":"Eric J Exelbert MD","profile_url":"https://wefunder.com/ericjexelbertmd"}],"relationships":[{"source_entity_id":"wefunder:company:75254","relation":"has_team_member","target_entity_id":"wefunder:user:1285846","target_url":"https://wefunder.com/b.renee.searle.2"},{"source_entity_id":"wefunder:company:75254","relation":"has_featured_investor","target_entity_id":"wefunder:user:1468760","target_url":"https://wefunder.com/ericjexelbertmd"},{"source_entity_id":"wefunder:company:75254","relation":"has_latest_fundraise","target_entity_id":"wefunder:fundraise:41077"}],"faq":[{"question":"What you’re doing is interesting, but I have a few questions: 1) If I understand everything correctly, it looks like the bulk of the nearly $1.9M in revenues earned in 2019 came from equipment sales by Washington State Enterprises, Inc. (WSE). Is WSE still a viable entity, and...","answer":"1. WSE is still a viable entity but we are not currently promoting the equipment sales aggressively. Equipment sales involved engineering and on-site set-up and management which were not possible during the covid lock-down. At that time we had already decided to change direction and promote the formulas which were a result of our research. Covid forced us into lock-down giving us time to set up our own labs and manufacturing facilities to produce our formulas. WSE still has approximately $50,..."},{"question":"What are revenues year-to-date, and did you achieve your goal of being cash-flow positive by the end of summer?","answer":"Summers not over yet. We got off to a slow start and had to re-hire and train. I expect that we should be cash-flow positive by November."}],"recent_posts":[],"provenance":{"source":"wefunder_public_company_profile","as_of":"2026-06-23T02:24:45Z","claims":{"total_amount_raised":{"source":"FrontCompanySummary#amount_raised","last_verified_at":"2026-06-22T05:03:15Z","as_of":"2026-06-23T02:24:45Z","confidence":"high"},"total_investors":{"source":"FrontCompanySummary#number_of_investors","last_verified_at":"2026-06-22T05:03:15Z","as_of":"2026-06-23T02:24:45Z","confidence":"high"},"active_raise_states":{"source":"Fundraise.visible(nil, nil)","last_verified_at":"2025-02-06T01:17:55Z","as_of":"2026-06-23T02:24:45Z","confidence":"high"},"latest_fundraise_state":{"source":"Fundraise.visible(nil, nil).order(funding_started_at)","last_verified_at":"2025-02-06T01:17:55Z","as_of":"2026-06-23T02:24:45Z","confidence":"medium"}}}}}}